Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for bleeding reduction during rhinoplasty
IRCT20170120032069N7Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epistaxis comparing Desmopressin with Placebo (2 arms). Primary endpoints: Intraoperative bleeding volume and Surgeon-rated bleeding score. Started Jul 2020; status: completed.
02
Drugs
desmopressin
03
Conditions
epistaxis
Beyond the preview
Go deeper on IRCT20170120032069N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170120032069N7.